Drug archive
Darbepoetin alfa (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antianemic
Description
Darbepoetin alfa ( dar-be-POE-e-tin AL-fa) stimulates the bone marrow to produce red blood cells. If the body does not produce enough red blood cells, severe anemia can occur. This often occurs in people with chronic kidney failure whose kidneys are not working properly. Anemia can also occur in people who have cancer and are receiving chemotherapy to treat their cancer. Darbepoetin alfa is used to treat severe anemia in these people. Darbepoetin may be used for patients on dialysis and for patients not on dialysis.
Darbepoetin alfa is given by injection. It is available only with your doctor's prescription and is available in the following dosage form:
- Injection (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Aranesp
In Canada -
- Aranesp